In further analysis, we included these four factors into a multivariate logistic regression, and finally found two factors, low proportion of lymphocyte and using G-CSF early, that increased and decreased the risk of viral infection after CAR-T therapy, respectively. The gene discussed is CSF3; the disease is viral infectious disease.